Current Status of the Diagnosis andManagement of Osteoporosis
Metadata
Show full item recordAuthor
Aibar-Almazán, Agustín; Voltes Martínez, Ana; Castellote Caballero, Yolanda; Afanador Restrepo, Diego Fernando; Carcelén-Fraile, María del Carmen; López Ruiz, ElenaEditorial
MDPI
Materia
osteoporosis regenerative medicine lifestyle habits
Date
2022-08-21Referencia bibliográfica
Aibar Almazán, A. et. al. Int. J. Mol. Sci. 2022, 23, 9465. [https://doi.org/10.3390/ijms23169465]
Sponsorship
1381650 from the 2014–2020 Operational Programme FEDER in Andalusia and the Mutua Madrileña Foundation: FMM-AP17196-2019Abstract
Osteoporosis has been defined as the silent disease of the 21st century, becoming a public
health risk due to its severity, chronicity and progression and affecting mainly postmenopausal
women and older adults. Osteoporosis is characterized by an imbalance between bone resorption and
bone production. It is diagnosed through different methods such as bone densitometry and dual Xrays.
The treatment of this pathology focuses on different aspects. On the one hand, pharmacological
treatments are characterized by the use of anti-resorptive drugs, as well as emerging regenerative
medicine treatments such as cell therapies and the use of bioactive hydrogels. On the other hand,
non-pharmacological treatments are associated with lifestyle habits that should be incorporated, such
as physical activity, diet and the cessation of harmful habits such as a high consumption of alcohol or
smoking. This review seeks to provide an overview of the theoretical basis in relation to bone biology,
the existing methods for diagnosis and the treatments of osteoporosis, including the development of
new strategies.